Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 2.1 Agreement and Plan of Merger, Dated April 7, 2014, by and Among Oro Capital Corporation, Synergy Merger Sub, Inc. and Synergy Strips Corp
- 2.2 Asset Purchase Agreement, Dated January 16, 2015, by and Among Synergy Strips Corp.; Factor Nutrition Labs, LLC; Vita Partners, LLC, RPR Partners, LLC, and Thor Associates, Inc
- 2.3 Asset Purchase Agreement, Dated June 26, 2015, by and Between Neuragen Corp. and Knight Therapeutics, Inc
- 3.1 Articles of Incorporation, As Amended
- 3.2 Bylaws
- 3.3 Amendment to Bylaws
- 3.4 Form of Amended and Restated Bylaws, to Be In Effect Upon Consummation of This Offering
- 10.1 Sales and Marketing Consultant and Distribution Agreement, Dated April 2, 2014, Between Synergy Strips Corp. and Kenek Brands Inc
- 10.2 Loan Agreement, Dated January 22, 2015, Between Knight Therapeutics (Barbados) Inc. and Synergy Strips Corp
- 10.3 Distribution, License and Supply Agreement, Dated January 22, 2015, by and Between Synergy Strips Corp. and Knight Therapeutics (Barbados) Inc
- 10.4 Synergy Strips Corp. 2014 Stock Incentive Plan
- 10.5 Synergy CHC Corp. 2024 Equity Incentive Plan
- 10.6 Contribution Agreement, Dated August 18, 2015, Among Hand MD, LLC, Principal Owners As Listed Therein, Synergy CHC Corp. and Hand MD Corp
- 10.7 Intellectual Property License Agreement, Dated August 18, 2015, by and Between Synergy CHC Corp. and Hand MD Corp
- 10.8 Stock Purchase Agreement, Dated November 12, 2015, by and Among Breakthrough Products, Inc., Urx Acquisition Trust, Jordan Eisenberg, Other Shareholders As Listed Therein and Synergy CHC Corp
- 10.9 Share Purchase Agreement, Dated November 15, 2015, Between TPR Investments Pty LTD Can 128 396 654 As Trustee for Polmear Family Trust, Timothy Polmear and Rebecca Polmear, Nomadchoice Pty Limited Acn 160 729 939 Trading As Flat Tummy Tea and Synergy
- 10.10 First Amendment to Loan Agreement, Dated November 12, 2015, Between Knight Therapeutics (Barbados) Inc. and Synergy CHC Corp
- 10.11 Amendment to First Amendment Agreement, Dated December 3, 2015, Between Knight Therapeutics (Barbados) Inc. and Synergy CHC Corp
- 10.12 Amendment and Confirmation Agreement, Dated December 3, 2015, by and Among Knight Therapeutics (Barbados) Inc., Nomad Choice Pty LTD., Synergy CHC Corp. and Breakthrough Products, Inc
- 10.13 Settlement and Release Agreement, Dated December 17, 2015, by and Between Synergy CHC Corp., the Former Shareholders of Breakthrough Products, Inc. and Urx Acquisition Trust on Its Own Behalf and As Representative of Certain Shareholders
- 10.14 Hand MD Distribution Agreement (Canada), Dated December 23, 2016, Between Knight Therapeutics Inc. and Synergy CHC Corp
- 10.15 Focusfactor Distribution Agreement (Canada), Dated December 23, 2016, Between Knight Therapeutics Inc. and Synergy CHC Corp
- 10.16 Asset Purchase Agreement, Dated June 21, 2017, Among Synergy CHC Corp., Perfekt Beauty Holdings LLC and CDG Holdings, LLC
- 10.17 Amended and Restated Loan Agreement, Dated August 9, 2017, Between Knight Therapeutics (Barbados) Inc. and Synergy CHC Corp
- 10.18 First Amendment to Amended and Restated Loan Agreement, Dated May 14, 2018, Between Knight Therapeutics (Barbados) Inc. and Synergy CHC Corp
- 10.19 Second Amendment to Amended and Restated Loan Agreement, Dated March 27, 2019, Between Knight Therapeutics (Barbados) Inc. and Synergy CHC Corp
- 10.20 Third Amendment Agreement, Dated May 8, 2020, Between Knight Therapeutics (Barbados) Inc. and Synergy CHC Corp
- 10.21 Fourth Amendment Agreement, Dated July 7, 2022, Between Knight Therapeutics (Barbados) Inc. and Synergy CHC Corp
- 10.22 Fifth Amendment Agreement, Dated September 30, 2023, Between Knight Therapeutics (Barbados) Inc. and Synergy CHC Corp
- 10.23 Sixth Amendment Agreement, Dated June 6, 2024, Between Knight Therapeutics (Barbados) Inc. and Synergy CHC Corp
- 10.24 Distribution Agreement (Canada), Dated February 15, 2016, Between Knight Therapeutics Inc. and Nomad Choice Pty LTD
- 10.25 Distribution Agreement (Remaining Territories), Dated February 15, 2016, Between Knight Therapeutics (Barbados) Inc. and Nomad Choice Pty LTD
- 10.26 Distribution Agreement (Canada), Dated January 1, 2017, Between Knight Therapeutics Inc. and Sneaky Vaunt Corp
- 10.27 Distribution Agreement (Remaining Territories), Dated January 1, 2017, Between Knight Therapeutics (Barbados) Inc. and Sneaky Vaunt Corp
- 10.28 Costco Wholesale Basic Vendor Agreement, Dated October 9, 2009, Between Factor Nutrition Labs LLC and Costco Wholesale Corporation
- 10.29 Supplier Agreement by and Among Factor Nutrition Labs LLC and Wal-mart Stores, Inc., Wal-mart Stores East, LP, Wal-mart Stores East, Inc., Wal-mart Stores Texas, LP, Sam's West, Inc., and Sam's East, Inc
- 10.30 Master Vendor Agreement, Dated July 26, 2022, Between Iherb, LLC and Synergy CHC Corp
- 10.31 Merchant Loan Agreement, Dated January 29, 2024, Between Webbank and Synergy CHC Corp
- 10.32 Merchant Loan Agreement, Dated May 1, 2024, Between Webbank and Synergy CHC Corp
- 10.33 Promissory Note, Dated February 10, 2022, by Synergy CHC Corp. In Favor of Don Sanders
- 10.34 Form of Securities Purchase Agreement, Dated March 8, 2022, by and Between Synergy CHC Corp. and the Purchasers Identified on the Signature Pages Thereto
- 10.35 Form of Senior Subordinated Debenture Due September 8, 2022
- 10.36 Modification Agreement, Dated June 14, 2023, by and Among Sanders Morris Harris, LLC, MR. Don A. Sanders and Synergy CHC Corp
- 10.37 Modification Agreement, Dated March 31, 2024, by and Among Sanders Morris Harris, LLC, Don A. Sanders and Synergy CHC Corp
- 10.38 Form of Indemnification Agreement
- 14.1 Code of Business Ethics and Conduct
- 21.1 List of Subsidiaries of the Registrant
- 23.1 Consent of RBSM LLP
- 99.1 Clawback Policy
- 99.2 Consent of Nitin Kaushal to Be Listed As a Director Nominee
- 99.3 Consent of Scott Woodburn to Be Listed As a Director Nominee
- EX-FILING FEES Filing Fee Table
Associated filings
- 23 Oct 24 424B4 Prospectus supplement with pricing info
- 23 Oct 24 EFFECT Notice of effectiveness
- 15 Oct 24 S-1/A IPO registration (amended)
- 10 Oct 24 S-1/A IPO registration (amended)
- 16 Sep 24 S-1/A IPO registration (amended)
- 9 Sep 24 S-1/A IPO registration (amended)
- 28 Aug 24 S-1/A IPO registration (amended)
- 13 Aug 24 S-1/A IPO registration (amended)
- 29 Jul 24 S-1/A IPO registration (amended)
-
28 Jun 24 S-1 IPO registration
SNYR similar filings
Filing view
External links
Exhibit 107
Calculation of Filing Fee Tables
Form S-1
Synergy CHC Corp.
Table 1: Newly Registered Securities
Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price(1) | Fee Rate | Amount of Registration Fee(2) | |||||||||||||||||||
Fees to Be Paid | Equity | Common Stock, par value $0.00001 per share(3)(4) | 457(o) | — | — | $ | 23,000,000 | 0.00014760 | $ | 3,394.80 | ||||||||||||||||
Other | Representative’s Warrants(5) | Other | — | — | — | — | — | |||||||||||||||||||
Equity | Common Stock issuable upon the exercise of the Representative’s Warrants(6) | 457(o) | — | — | $ | 2,530,000 | 0.00014760 | $ | 373.43 | |||||||||||||||||
Total Offering Amounts | $ | 25,530,000 | — | $ | 3,768.23 | |||||||||||||||||||||
Total Fee Offsets | — | — | — | |||||||||||||||||||||||
Net Fee Due | — | — | $ | 3,768.23 |
(1) | Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”). |
(2) | Calculated pursuant to Rule 457(o) under the Securities Act based on an estimate of the proposed maximum aggregate offering price. |
(3) | Includes up to an additional 15% of the aggregate offering price to cover a 30-day option granted to the underwriters to purchase additional shares of our common stock to cover over-allotments, if any. |
(4) | Pursuant to Rule 416(a) of the Securities Act, the shares of common stock registered hereby also includes an indeterminable number of additional securities that may be issued to prevent dilution resulting from stock splits, stock dividends or similar transactions. |
(5) | No fee required pursuant to Rule 457(g). |
(6) | We have agreed to issue to the representative of the underwriters (the “Representative”), upon the closing of this offering, warrants to purchase up to an aggregate number of shares of our common stock (the “Representative’s Warrants”) in an aggregate equal to ten percent (10%) of the aggregate number of shares of common stock to be issued and sold in this offering. The Representative’s Warrants are exercisable at a per share price equal to 110% of the public offering price per share of the shares of common stock sold in this offering. |